Jose Iglesias, M.D. brings decades of expertise in clinical development strategy, clinical trial design, biomarker-guided pharmacodynamics, proof of principle and proof of concept studies, drug approval strategies, studies to support commercialization, academic research collaborations, and liaisons with worldwide centers of excellence, and oncology cooperative groups. Dr. Iglesias served as Chief Medical Officer at Senti Biosciences, Biothera Pharmaceuticals, Bionomics Ltd., Abraxis Bioscience Inc., and as Vice President, Clinical Development at Celgene.
Org chart
This person is not in the org chart
Teams
Offices
This person is not in any offices
IMV
IMV - multiple clinical-stage candidates in immuno-oncology and infectious disease, with a focus on combination therapies.
